WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006087205) LIVE ATTENUATED ROTAVIRUS VACCINE FOR ORAL ADMINISTRATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/087205    International Application No.:    PCT/EP2006/001442
Publication Date: 24.08.2006 International Filing Date: 15.02.2006
Chapter 2 Demand Filed:    28.07.2006    
IPC:
A61K 39/15 (2006.01), A61P 1/00 (2006.01)
Applicants: GLAXOSMITHKLINE BIOLOGICALS S.A. [BE/BE]; Rue De L'institut 89, B-1330 Rixensart (BE) (For All Designated States Except US).
VANDE VELDE, Vincent [BE/BE]; (BE) (For US Only)
Inventors: VANDE VELDE, Vincent; (BE)
Agent: CREPIN, Carine; GlaxoSmithKline, Corporate Intellectual Property (cn925.1), 980 Great West Road, Brentford Middlesex TW8 9GS (GB)
Priority Data:
0503337.8 17.02.2005 GB
Title (EN) LIVE ATTENUATED ROTAVIRUS VACCINE FOR ORAL ADMINISTRATION
(FR) VACCIN A BASE DE ROTAVIRUS VIVANT ATTENUE POUR ADMINISTRATION ORALE
Abstract: front page image
(EN)The invention provides liquid rotavirus formulations that are suitable for oral administration to human infants. In particular the invention provides pharmaceutical compositions and vaccines, comprising a rotavirus antigen, a sugar and a carboxylate wherein said formulation has a pH of between pH 5.0 and pH 8.0 and comprises no phosphate or less than 5 mM phosphate. The invention also provides methods of preparing said rotavirus formulations and use thereof in the prevention or treatment of rotavirus associated diseases in humans.
(FR)La présente invention concerne des formulations liquides de rotavirus qui conviennent pour une administration orale aux nourrissons humains. En particulier, l’invention concerne des compositions pharmaceutiques et des vaccins comprenant un antigène de rotavirus, un sucre et un carboxylate, leur formulation ayant un pH compris entre pH 5.0 et pH 8.0 et ne comprenant pas de phosphate ou moins de 5 mM de phosphate. Cette invention décrit également des procédés de préparation desdites formulations de rotavirus et l’utilisation de celles-ci dans la prévention ou le traitement des maladies associées au rotavirus chez les humains.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)